ARDT (Ardent Health) Research & Development: $0 Mil (TTM As of Mar. 2026)


ARDT Ardent Health Inc ARDT
39 GF Score
Price $9.93
! 2 Warning Signs
View Full Analysis

What is Ardent Health Research & Development?

Ardent Health ARDT +2.06% 39 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates ARDT with a GF Score™ of 39/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ardent Health's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Ardent Health  (NYSE:ARDT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ardent Health Research & Development Related Terms

Ardent Health Research & Development Historical Data

* Premium members only.

The historical data trend for Ardent Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ardent Health Research & Development Chart

Ardent Health Annual Data
Trend Dec16 Dec17 Dec18 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Ardent Health Quarterly Data
Dec16 Dec17 Sep18 Dec18 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ARDT
39GF Score
Ardent Health Inc ARDT
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ardent Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Ardent Health (ARDT) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ardent Health and its competitors.
Is Ardent Health's Research & Development too high?
Ardent Health's current Research & Development is $0 Mil. Overall, Ardent Health has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Ardent Health's Research & Development compare to INNV and AMN?
Ardent Health's Research & Development of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ardent Health and its competitors. Ardent Health's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ardent Health stock overvalued right now?
Ardent Health (ARDT) has a current Research & Development of $0 Mil. The current Research & Development is $0 Mil. Ardent Health's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ardent Health (ARDT), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ardent Health Business Description

Address 340 Seven Springs Way, Suite 100, Brentwood, TN, USA, 37027
Ardent Health Inc is a provider of healthcare in growing mid-sized urban communities across the U.S and operating in eight growing mid-sized urban markets across six states Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. The main focus on people and investments in services and technologies.
39GF Score

Get the complete analysis for ARDT

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.93
Price